From: Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma
Clinicopathologic variables | Number | Average survival | P value |
---|---|---|---|
All patients | 45 | 16.005 ± 2.360 | |
Gender | |||
Male | 24 | 13.786 ± 2.595 | 0.518 |
Female | 21 | 18.087 ± 3.903 | |
Age at diagnosis | |||
< 55 | 24 | 19.163 ± 4.097 | 0.501 |
≥ 55 | 21 | 13.148 ± 1.726 | |
KPS | |||
< 70 | 11 | 8.273 ± 2.149 | 0.018* |
≥ 70 | 34 | 16.005 ± 2.360 | |
Headache | |||
Yes | 21 | 12.551 ± 1.532 | 0.775 |
No | 24 | 17.104 ± 3.520 | |
Intracranial infection | |||
Yes | 3 | 6 ± 4.041 | 0.05 |
No | 42 | 16.752 ± 2.489 | |
Multiple lobe lesions | |||
Yes | 11 | 15.697 ± 3.715 | 0.727 |
No | 34 | 15.913 ± 2.815 | |
RND1 expression | |||
High | 22 | 20.801 ± 3.912 | 0.007* |
Low | 23 | 10.947 ± 1.828 |